2nd Global Summit on Oncology & Cancer March 12-14, 2018 Singapore

Dr. Junliang Liu underwent his radiation oncology residency in University of Manitoba, Canada from year 2000 to 2005. Since July 2005, he has been an attending radiation oncologist working at CancerCare Manitoba, Canada. He was the radiation oncology residency program director from 2006 to 2012. Dr. Liu earned a Ph.D., and conducted post-doctoral research in immunology. His publications included the one in Nature Medicine and PNAS. His current research interest is the treatment outcomes of gastrointestinal malignancies, breast cancer, and metastatic cancer.

Treatment outcome analyses in breast and gastrointestinal malignancies with emphasis on prognostic factors.

Dr. Polly Chen is an Assistant Professor in the Department of Anatomy and a principle investigator at the Cancer Science Institute of Singapore, National University of Singapore where she directs a research lab studying human cancers, particularly liver cancer. Her group currently focuses on the identification of key RNA editing events and translating these findings into diagnoses and even treatment. In addition, she has begun collaborating with local and international researchers to study the roles of RNA editing enzyme ADARs and their substrates in different types of human cancers, such as esophageal squamous cell carcinoma (ESCC), Gastric cancer and acute myeloid leukemia (AML).

Hepatocellular carcinoma (HCC), Transcriptome instability of human cancers, Regulation of tumorigenesis by transcriptome instability.

Dr. Lingzhi Wang is a Senior Research Scientist at the Cancer Science Institute of Singapore and an Assistant Professor in the Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (NUS). Dr. Wang obtained his M.Med. in Medicinal Chemistry from Chongqing Medical University in 1993. He continued his postgraduate studies in NUS and obtained his M.Sc. in Pharmacy and Ph.D. in Pharmacology in 2003 and 2008, respectively. Dr. Wang received the Medical Research Scientist Award from the National Medical Research Council (NMRC Singapore) in 2005, and the PhD Graduate Research Excellence Award from the American Association of Pharmaceutical Scientists (AAPS) at its Annual Meeting in 2008 (USA). To date, he is the author of over 70 research papers, including articles in Cell, Journal of Clinical Oncology, Clinical Cancer Research, Trends in Pharmacology, and Trends in Biotechnology etc.

His research interests are in the development of novel combination therapies against a variety of cancers, identification of anticancer agents from natural products, preclinical cancer pharmacology, and discovery of bio-fluid exosomal biomarkers for cancer diagnosis.

Carrie Yuen is a Hong Kong native and a board certified internist and pediatrician. She has many years of clinical practice experience and has a particular interest in immunology and translational research on cellular therapy. Her passion is to improve the understanding of disease process, GVHD, and to investigate potential application of cellular therapy in the field of transplant with a goal of improving overall survival and minimize toxicity of current transplant regimens. She joined the faculty at the Stephenson Cancer Center in 2012. She is an assistant professor in the Section of Hematology/Oncology and works primarily with the Blood and Marrow Transplant Program.

Hematologic malignancies, Benign hematology, Bone marrow transplant, Pediatric long-term cancer survivor.

Caroline Lee graduated with PhD from Baylor College of Medicine and did her post-doctoral training at the National Cancer Institute, National Institutes of Health. She currently also holds joint appointment as Principal Investigator at the National Cancer Centre as well as an Associate Professor at the Cancer and Stem Cell Biology Program at Duke-NUS Graduate Medical School. She has ~100 peer reviewed publications and research focuses on the functional genomics of hepatocellular carcinoma (HCC) and pharmacogenetics.

Pharmacogenetics, Tumorigenesis, Cancer Functional Genomics, Carcinogenesis, Identify Biomarkers for hepatocellular carcinoma (HCC).

Peter obtained his B.Sc (Hons) in Microbiology from University of Malaya in 1992 and a Doctor of Philosophy (D.Phil) in Biochemistry/Molecular Biology from Exeter College, University of Oxford in 1998. He was a Research Scientist, and Head of Microarray Group with A-Star Bioprocessing Technology Institute in Singapore (2001 to 2010) prior to joining the Faculty of Engineering, Computing and Science, Swinburne University of Technology Sarawak Campus. His areas of expertise are molecular and cellular biology, system biology and genomics with specialization in high throughput gene expression profiling using DNA microarray and Next-Gen sequencing technologies. He has a H-index of 15 and have published journal papers and book chapters, in the subject area of genomics and gene expression analysis.

Identifying biomarkers from genomics and proteomics data, Biomarkers discovery for cancer and immune disorders, Exploring miRNAs as potential therapeutics targets.

Dr. Yonghua Yang is currently a professor in the Department of Biochemistry & Pharmacology of Fudan University with a focus on breast cancer. Dr. Yang obtained his B.S. in Organic Chemistry from Jilin University in 1987. He continued his postgraduate studies in Shanghai Institute of Materia Medica, CAS and obtained his Ph.D. in Pharmacy and Pharmacology in 1993 and 1998, respectively. He is working with trainees in his laboratory on the characterization and development of novel molecules significant in breast tumorigenesis. He published a series of first author and senior author publications in recognized peer-reviewed journals, including Nature Cell Biology, EMBO J, PNAS, Cancer Research, and Oncogene etc.

My current research focuses on exploring the roles and molecular mechanisms of cancer-related proteins in tumorigenesis and metastasis, as well as molecular targets for cancer therapeutics and anticancer drug development via molecular biology, cell biology, genetics and other approaches.